Full Press Release Details
DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million
Officially Launches Yield-Focused Digital Asset Treasury Strategy
Streamlines Operations, Achieving Approximately $2.9 Million in Annualized Cost Savings
BROOK, N.Y. - October 22, 2025 - Applied DNA Sciences, Inc. (NASDAQ: BNBX) ("Applied DNA", "BNBX"
or the "Company"), a biotechnology company advancing a yield focused BNB digital asset treasury strategy and commercializing
nucleic acid production solutions, today announced the successful close of its previously announced private investment in public equity
("PIPE") financing led by institutional DeFi and TradFi investors.
PIPE resulted in gross proceeds of approximately $27 Million to the Company, before deducting placement agent fees and other offering
expenses, with the potential for up to an additional $31 million in gross proceeds in the future from warrant exercises.
proceeds from the PIPE included $15.3 Million in cash and stablecoins and units of the OBNB trust valued at $11.71 million1.
The Company received 0.126 units of OBNB trust per prefunded warrant and common warrant for a total of 435,638 trust units representing
underlying ownership of 10,647 BNB tokens. The prefunded warrants and warrants issued in exchange for the OBNB trust units are not exercisable
until the receipt of stockholder approval and the OBNB units are transferred to the Company with marketable title free and clear of any
security interests, pledges, liens, restrictions, claims or encumbrances.
Company also announced today that it purchased an additional 4,908 BNB tokens with an estimated total value of $5.3M as of 10:00pm ET
on October 20, 2025.
are excited to launch our yield-focused BNB treasury strategy with significant direct and BNB equivalent token exposure," said
Patrick Horsman, CFA, Chief Investment Officer. "We see BNB as the next institutional grade blockchain and believe we're
well positioned to capitalize on its future growth."
As of October 20, 2025
Company intends to use the PIPE net proceeds to continue implementation of its BNB treasury strategy, support working capital needs,
and cover transaction-related expenses.
addition to launching our digital asset treasury, we believe we have taken decisive steps to streamline our cost structure and position
the Company for long-term sustainability" said Clay Shorrock, CEO of Applied DNA Sciences. "By aligning resources with strategic
priorities, we believe we are well-positioned to execute with discipline, deliver durable value to shareholders, and advance our differentiated
Capital Markets acted as sole placement agent for the Offering.
Will & Schulte LLP is acting as legal advisor to the Company.
Grossman & Schole LLP is acting as legal advisor to Lucid Capital Markets.
Moscou Faltischek PC is acting as legal advisor to Cypress Management.
offering is being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the Securities Act of 1933,
as amended (the "Securities Act"), and/or Regulation D promulgated thereunder, and applicable state securities laws. Accordingly,
the securities offered in the private placement may not be offered or sold in the United States except pursuant to an effective
registration statement or an applicable exemption from the registration requirement of the Securities Act and such applicable state securities
press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration
or qualification under the securities laws of any such state or other jurisdiction.
Applied DNA Sciences
DNA Sciences (BNBX) is unlocking institutional-grade access to the Binance ecosystem - delivering high-yield, risk-managed exposure
to the future of blockchain through a transparent, actively managed BNB treasury. BNBX's differentiated strategy blends sophisticated
DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally
excluded from this space. The Company is also commercializing proprietary nucleic acid production solutions for the biopharmaceutical
and diagnostics markets.
press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words
such as "anticipate," "expect," "plan," "could," "may," "will,"
"believe," "estimate," "forecast," "goal," "project," and other words of
similar meaning. Forward-looking statements are statements other than historical facts and address various matters including, without
limitation, statements relating to the assets to be held by the Company, the expected future market, price and liquidity of the digital
assets the Company acquires, the intended use of proceeds from the offering, statements regarding the potential for and amount of additional
cash proceeds from warrant exercise, the macro and political conditions surrounding digital assets, the Company's plan for value
creation and strategic advantages, market size, market position, and growth opportunities, regulatory conditions, competitive position
and the interest of other corporations in similar business strategies, technological and market trends, future announcements and priorities,
expectations regarding management, future financial and operating condition and performance, the expected financial impacts of the proposed
transactions described herein and other projections or statements of plans and objectives.
forward-looking statements are based on current expectations, estimates, assumptions, and projections, and involve known and unknown
risks, uncertainties, and other factors-many of which are beyond the Company's control-that may cause actual results,
performance, or achievements to differ materially from those expressed or implied by such statements. Each forward-looking statement
contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those
expressed or implied by such statement. Applicable risks and uncertainties include, among others, failure to realize the anticipated
benefits of the proposed digital asset treasury strategy; changes in business, market, financial, political and regulatory conditions;
risks relating to the Company's operations and business, including the highly volatile nature of the price of BNB and other cryptocurrencies;
the illiquidity of the OBNB units owned by the Company, risks related to the Company's ability to raise and deploy capital effectively;
risks relating to an unproven yield generation strategy, the risk that the price of the Company's common stock may be highly correlated
to the price of the digital assets that it holds; risks related to increased competition in the industries in which the Company does
and will operate; risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally;
risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; risks related to the unknown returns, liquidity
and/or token accumulation that the Company's BNB treasury strategy will generate; risks relating to market volatility, cybersecurity
and custody of digital assets, potential changes in laws or accounting standards relating to cryptocurrency, and regulatory developments
affecting BNB or other digital assets; as well as those risks and uncertainties identified in the Company's filings with the Securities
and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and the Company
undertakes no obligation to update or revise any of these statements.
Relations contact: John Ragozzino Jr., CFA BnB@icrinc.com